30 participants
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-19
- Start Date:
- 2024-06-11
- Completion:
- 2030-04-30
Conditions
- Anatomic Stage I Breast Cancer
- Anatomic Stage II Breast Cancer
- Anatomic Stage III Breast Cancer
- Invasive Breast Lobular Carcinoma
Interventions
- PROCEDURE
- DRUG
No Results Yet